Position in EXEL
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$1,088
+$231 QoQ
Shares Held
20
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#715
of 739 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Mosley Wealth Management holds $36,238 across 6 Biotechnology names. EXEL ranks #4 (3.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
47 | $29,306 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
9 | $4,470 | |
| 3 | PBYI |
Puma Biotechnology, Inc.
|
148 | $1,200 | |
| 4 | EXEL |
Exelixis, Inc.
This page
|
20 | $1,088 | |
| 5 | PCVX |
Vaxcyte, Inc.
|
3 | $174 | |
| 6 | RVPH |
Reviva Pharmaceuticals Holdings, Inc.
|
1 | $0 |
All Filings in EXEL
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,088 | 20 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $857 | 20 | Shares | Sole | 2026-04-27 | |
| No filing history on record for this holder in this stock. | ||||||